Drug Shortage Report for ROBAXISAL C 1/2
Report ID | 136006 |
Drug Identification Number | 01934791 |
Brand name | ROBAXISAL C 1/2 |
Common or Proper name | NA |
Company Name | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC |
Market Status | MARKETED |
Active Ingredient(s) | CODEINE PHOSPHATE METHOCARBAMOL ACETYLSALICYLIC ACID |
Strength(s) | 32.4MG 400MG 325MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 250 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-07-05 |
Actual start date | |
Estimated end date | 2022-10-10 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-07-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 55 STANDISH COURT MISSISSAUGA, ONTARIO CANADA L5R 4B2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-07-06 | French | Compare |
v7 | 2022-07-06 | English | Compare |
v6 | 2022-02-02 | French | Compare |
v5 | 2022-02-02 | French | Compare |
v4 | 2022-02-02 | English | Compare |
v3 | 2021-07-06 | English | Compare |
v2 | 2021-03-19 | French | Compare |
v1 | 2021-03-19 | English | Compare |
Showing 1 to 8 of 8